Longview Acquisition Corp. II (NYSE:LGV) and medtech firm HeartFlow announced this afternoon that they have opted to mutually terminate their business combination agreement.
On November 15, 2021, Longview requested that HeartFlow management undertake a thorough financial analysis of its projections. Following the conclusion of the analysis, and extensive mutual efforts to negotiate an appropriate valuation adjustment, both parties agreed to terminate the deal. The deal was originally struck with a minimum cash condition of $345 million, but did not include a PIPE.
The SPAC also stated that it intends to continue to pursue a target for a business combination. Longview II has a little over one year left on its SPAC clock with a completion deadline of March 23, 2023, a significant amount of time to find another target.
Longview II and HeartFlow originally announced their intended $2.4 billion combination on July 15, 2021, a little over six months ago. Redwood City, California-based HeartFlow provides tools for visualizing blood circulation around the heart, giving physicians insights into further treatment options.
Longview II is led by CEO John Rodin, Chairman Larry Robbins, and CFO Mark Horowitz.
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...